KFF Health News’ ‘What the Health?’: Trump’s ‘One Big Beautiful Bill’ Lands in Senate. Our 400th Episode!

The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…

Read More

RFK Jr. Exaggerates Share of Autistic Population With Severe Limitations

Health and Human Services Secretary Robert F. Kennedy Jr. attracted notice — and in some quarters, outrage — for remarks about autism, a topic he’s clashed with scientists about for years. Kennedy held an April 16 press conference pegged to a new Centers for Disease Control and Prevention report that found the prevalence of autism rising to 1 in 31 among 8-year-olds, the…

Read More

Health Provisions in the 2025 Federal Budget Reconciliation Law

On July 4, President Trump signed the budget reconciliation bill, previously known as the “One Big Beautiful Bill Act,” into law. This summary provides background, description, budgetary impact and related information on the health care provisions of the law in four categories: Medicaid, the Affordable Care Act, Medicare and Health Savings Accounts (HSAs).

Read More

Carrot Fertility Unveils Virtual Menopause and Midlife Health Clinic

Carrot Fertility’s new menopause and midlife health clinic, called Telemedicine for Menopause, will become available to U.S. members with a Carrot Plan starting in March. Members will be able to schedule a telehealth appointment with a menopause specialist and receive prescriptions for hormone therapy and other menopause-related medications if needed. The post Carrot Fertility Unveils…

Read More

Battle Royale: Small molecules vs. biologics

The Inflation Reduction Act (IRA) allows the Centers for Medicare and Medicaid Services to negotiate drug prices. However, CMS can only negotiated drug prices 9 years after drug approval for small molecules and 13 years after approval for large molecules. Why the difference? Do biologic treatments produce superior health benefits for patients? This is the…

Read More